Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

LIBERTY ASTHMA TRAVERSE Trial: Long-Term Safety and Efficacy of Dupilumab in Moderate-to-Severe Asthma

LIBERTY ASTHMA QUEST Trial: Dupilumab Efficacy in Eosinophilic (≥500 cells/µL) and Allergic Asthma Subgroups

LIBERTY ASTHMA QUEST Trial: Dupilumab Efficacy in Type 2 Asthma Patients on High-Dose ICS

Dupilumab improves clinical outcomes in patients with severe asthma compared to other biologics

Bullous Pemphigoid Burden of Disease and Diagnosis

MS pulse Reels - How to Track MS | Acknowledge, Assess, Advocate

Discover a simple way to monitor MS using Acknowledge, Assess, and Advocate—helping you track changes and improve patient conversations.

MS pulse Reels - See the Bigger Picture: Why Tracking Matters

MS changes are often hard to notice day by day. This video shows how tracking over time helps you see the bigger picture and what’s really changing.

MS Pulse Reels - MS Monitoring in Practice | Turning Tracking into Action

See how tracking MS symptoms over time can lead to better insights, stronger discussions, and more informed care decisions.

CRSwNP EVEREST

How can you see changing the lives of patient starting taking Nexviazyme and if you can share from your experience couple of patient stories that realy impacted positively from staring the treatment for Pompe disease?

From your experience

Thank You!

The End

What makes avalglucosidase alfa different from alglucosidase alfa in terms of clinical efficacy and patient outcomes?

Advances in Therapy: Avalglucosidase Alfa & Future Innovations